Literature DB >> 16895919

CFBP is a novel tyrosine-phosphorylated protein that might function as a regulator of CIN85/CD2AP.

Hiroaki Konishi1, Kyoko Tashiro, Yasunobu Murata, Hiromi Nabeshi, Emiko Yamauchi, Hisaaki Taniguchi.   

Abstract

To decipher the global network of the epidermal growth factor (EGF) receptor-mediated signaling pathway, a large scale proteomic analysis of tyrosine-phosphorylated proteins was conducted. Here, we focus on characterizing a novel protein, CFBP (CIN85/CD2AP family binding protein), identified in the study. CFBP was found to be phosphorylated at tyrosine 204 upon EGF stimulation, and the CIN85/CD2AP family was identified as a binding partner. A proline-rich motif of CFBP is recognized by one of the three Src-homology 3 domains of CIN85/CD2AP, and the affinity of the interaction is regulated by the tyrosine phosphorylation of CFBP. They co-localize in actinenriched structures, and overexpression of CFBP induced morphological changes with actin reorganization. Furthermore, CFBP accelerated the EGF receptor's down-regulation by facilitating the recruitment of Cbl to the CD2AP/CIN85 complex. Two spliced variants of CFBP lacking either exon 5 or 8 are also expressed, and the variant lacking exon 5 without the proline-rich motif lacks the ability to bind to the CIN85/CD2AP family. The CFBP protein seems to play a key role in the ligand-mediated internalization and down-regulation of the EGF receptor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16895919     DOI: 10.1074/jbc.M605693200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  CD2AP regulates SUMOylation of CIN85 in podocytes.

Authors:  Irini Tossidou; Rainer Niedenthal; Malte Klaus; Beina Teng; Kirstin Worthmann; Benjamin L King; Kevin J Peterson; Hermann Haller; Mario Schiffer
Journal:  Mol Cell Biol       Date:  2011-12-27       Impact factor: 4.272

2.  A brain-specific Grb2-associated regulator of extracellular signal-regulated kinase (Erk)/mitogen-activated protein kinase (MAPK) (GAREM) subtype, GAREM2, contributes to neurite outgrowth of neuroblastoma cells by regulating Erk signaling.

Authors:  Tomonori Taniguchi; Shigeru Tanaka; Ayumi Ishii; Miyuki Watanabe; Noriko Fujitani; Ayusa Sugeo; Shuhei Gotoh; Takeshi Ohta; Mineyoshi Hiyoshi; Hideki Matsuzaki; Norio Sakai; Hiroaki Konishi
Journal:  J Biol Chem       Date:  2013-09-03       Impact factor: 5.157

3.  UMA and MABP domains throw light on receptor endocytosis and selection of endosomal cargoes.

Authors:  Robson F de Souza; L Aravind
Journal:  Bioinformatics       Date:  2010-05-06       Impact factor: 6.937

4.  GAREM, a novel adaptor protein for growth factor receptor-bound protein 2, contributes to cellular transformation through the activation of extracellular signal-regulated kinase signaling.

Authors:  Kyoko Tashiro; Takumi Tsunematsu; Hiroko Okubo; Takeshi Ohta; Etsuko Sano; Emiko Yamauchi; Hisaaki Taniguchi; Hiroaki Konishi
Journal:  J Biol Chem       Date:  2009-06-09       Impact factor: 5.157

Review 5.  Membrane protein targeting to the MVB/lysosome.

Authors:  Brian A Davies; Jacqueline R E Lee; Andrea J Oestreich; David J Katzmann
Journal:  Chem Rev       Date:  2009-04       Impact factor: 60.622

6.  MVB-12, a fourth subunit of metazoan ESCRT-I, functions in receptor downregulation.

Authors:  Anjon Audhya; Ian X McLeod; John R Yates; Karen Oegema
Journal:  PLoS One       Date:  2007-09-26       Impact factor: 3.240

7.  Behavioral analysis in mice deficient for GAREM2 (Grb2-associated regulator of Erk/MAPK subtype2) that is a subtype of highly expressing in the brain.

Authors:  Tasuku Nishino; Kota Tamada; Akane Maeda; Takaya Abe; Hiroshi Kiyonari; Yasuhiro Funahashi; Kozo Kaibuchi; Toru Takumi; Hiroaki Konishi
Journal:  Mol Brain       Date:  2019-11-12       Impact factor: 4.041

8.  The molecular basis for selective assembly of the UBAP1-containing endosome-specific ESCRT-I complex.

Authors:  Lydia Wunderley; Kim Brownhill; Flavia Stefani; Lydia Tabernero; Philip Woodman
Journal:  J Cell Sci       Date:  2013-11-27       Impact factor: 5.285

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.